Rates of opioid misuse and related overdoses have soared in recent years in the United States, highlighting the importance of screening tools to identify patients at high risk for adverse events from opioid use.
The infants of women taking opioids concomitantly with psychotropic medications were found to have a substantially heightened risk of neonatal drug withdrawal.
The extended-release formulation of tramadol was shown to be as effective as buprenorphine and more effective than clonidine for treating symptoms of opioid withdrawal.
While opioid abuse among young adults had decreased, abuse rates in adults 50 years and older has doubled, from 1.1 to 2.0%.
A 12-week CBT program led to reductions in PTSD and substance abuse in transgender women with HIV.
The number of opioids prescribed in the US decreased between 2010 and 2015, but the overall rate remains high.
Highlights from the National Academies of Sciences, Engineering, and Medicine report titled "Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use."
According to the CDC, despite reductions in certain parts of the country, the amount of opioids being prescribed remains high compared with levels in 1999, with variations mostly seen at the county level.
Once-weekly subcutaneous buprenorphine injections block the euphoric effects of opioids and suppress opioid withdrawal in patients with opioid use disorder.
In infants with neonatal abstinence syndrome, sublingual buprenorphine reduced the duration of treatment and decreased the length of hospital stay.
More than half of all opioids prescribed in the United States are for patients who have a mental health disorder.
Patients with low back pain who are depressed are more likely to be prescribed opioids, and to be prescribed higher doses.
Strategies are being implemented to reduce opioid overdoses and deaths in Maryland.
Early pharmacologic intervention for opioid use disorder after diagnosis is crucial to prevent relapse and overdose in adolescents and young adults.
About 20% of U.S. bariatric surgery patients are still using prescription opioids 7 years later.
Discrepancies in Subjective vs Objective Sleep in Patients Receiving Buprenorphine for Opioid Use Disorder
Patients receiving buprenorphine maintenance therapy for their opioid use disorder may have impaired sleep, despite their reports of improved quality and duration of sleep.
Women are routinely prescribed more opioid medications than they need after cesarean sections, creating a high risk for misuse.
The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.
Polyneuropathy may increase the likelihood of patients receiving long-term opioid therapy.
Most opioid-dependent pregnant patients understand that intravenous drug use is a major transmission modality of hepatitis C virus.
The majority of PA students and practicing PAs did not feel that their PA program adequately trained them to screen for opioid abuse.
Clinical Pain Advisor Articles
- Intrathecal Ziconotide Long-Term Efficacy and Safety for Severe Chronic Pain
- Sciatic Plus Femoral Nerve Blocks Effective on Total Hip Arthroplasty-Related Pain
- Psychological Factors, Not Opioid Use, Linked with Disability After Fracture Surgery
- Acupressure Not Effective as Adjunctive Therapy to Sodium Valproate for Chronic Migraine With Aura
- Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia
- Yoga Improves Health Outcomes in Veterans With Chronic Low Back Pain
- The Advice You Give Your Patients May Be Just What They Need to Hear
- Childhood Adversity Common in Patients With Fibromyalgia, Chronic Widespread Pain
- Peripheral Nerve Stimulation Effective for Chronic Pain With Postherpetic Neuralgia
- Neonatal Withdrawal Risk Higher With Opioids Plus Psychotropic Drugs